Molecular mechanism of poliovirus Sabin vaccine strain attenuation

被引:12
|
作者
Avanzino, Brian C. [1 ]
Jue, Helen [1 ]
Miller, Clare M. [2 ]
Cheung, Emily [2 ]
Fuchs, Gabriele [2 ]
Fraser, Christopher S. [1 ]
机构
[1] Univ Calif Davis, Dept Mol & Cellular Biol, Coll Biol Sci, Davis, CA 95616 USA
[2] SUNY Albany, Dept Biol Sci, RNA Inst, Albany, NY 12222 USA
基金
美国国家卫生研究院;
关键词
poliovirus; eukaryotic translation initiation factor 4G (eIF4G); eukaryotic initiation factor 4A (eIF4A); RNA-binding protein; eukaryotic translation initiation; plus-stranded RNA virus; internal ribosome entry site (IRES); vaccine; virulence; TRACT-BINDING-PROTEIN; INTERNAL RIBOSOME ENTRY; HUMAN NEUROBLASTOMA; ATPASE ACTIVITIES; NONCODING REGION; HELICASE EIF4A; TRANSLATION; INITIATION; RNA; TYPE-3;
D O I
10.1074/jbc.RA118.004913
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recruitment of poliovirus (PV) RNA to the human ribosome requires the coordinated interaction of the viral internal ribosome entry site (IRES) and several host cellular initiation factors and IRES trans-acting factors (ITAFs). Attenuated PV Sabin strains contain point mutations in the PV IRES domain V (dV) that inhibit viral translation. Remarkably, attenuation is most apparent in cells of the central nervous system, but the molecular basis to explain this is poorly understood. The dV contains binding sites for eukaryotic initiation factor 4G (eIF4G) and polypyrimidine tract-binding protein (PTB). Impaired binding of these proteins to the mutant IRESs has been observed, but these effects have not been quantitated. We used a fluorescence anisotropy assay to reveal that the Sabin mutants reduce the equilibrium dissociation constants of eIF4G and PTB to the PV IRES by up to 6-fold. Using the most inhibitory Sabin 3 mutant, we used a real-time fluorescence helicase assay to show that the apparent affinity of an active eIF4G/4A/4B helicase complex for the IRES is reduced by 2.5-fold. The Sabin 3 mutant did not alter the maximum rate of eIF4A-dependent helicase activity, suggesting that this mutant primarily reduces the affinity, rather than activity, of the unwinding complex. To confirm this affinity model of attenuation, we show that eIF4G overexpression in HeLa cells overcomes the attenuation of a Sabin 3 mutant PV-luciferase replicon. Our study provides a quantitative framework for understanding the mechanism of PV Sabin attenuation and provides an explanation for the previously observed cell type-specific translational attenuation.
引用
收藏
页码:15471 / 15482
页数:12
相关论文
共 50 条
  • [21] RESPONSE OF INFANTS TO TRIVALENT POLIOVIRUS VACCINE (SABIN STRAINS)
    MURPHY, W
    PEDIATRICS, 1967, 40 (06) : 980 - &
  • [22] VIREMIA IN INFANTS VACCINATED WITH ORAL POLIOVIRUS VACCINE ( SABIN )
    HORSTMANN, DM
    VIGNEC, AJ
    LLADO, B
    OPTON, EM
    KLEMPERER, R
    AMERICAN JOURNAL OF HYGIENE, 1964, 79 (01): : 47 - &
  • [23] GENETIC-BASIS OF ATTENUATION OF THE SABIN ORAL POLIOVIRUS VACCINES
    MINOR, PD
    MACADAM, AJ
    STONE, DM
    ALMOND, JW
    BIOLOGICALS, 1993, 21 (04) : 357 - 363
  • [24] Immunogenicity and safety of sabin-strain based inactivated poliovirus vaccine replacing salk-strain based inactivated poliovirus vaccine: An innovative application of different strain-IPVs replacement
    Chen, Haiping
    Gao, Zhigang
    Bai, Shuang
    Liu, Xiaoqin
    Han, Shasha
    Xiao, Yanhui
    Liu, Fang
    Yu, Yinghong
    Sun, Hongmei
    Yang, Xiaoming
    VACCINE, 2021, 39 (17) : 2467 - 2474
  • [25] THERMOSENSITIVE BLOCK OF SABIN STRAIN OF POLIOVIRUS TYPE I
    FISZMAN, M
    REYNIER, M
    BUCCHINI, D
    GIRARD, M
    JOURNAL OF VIROLOGY, 1972, 10 (06) : 1143 - 1151
  • [26] EVALUATION OF SABIN LIVE POLIOVIRUS VACCINE IN JAPAN .3. STUDIES ON METHOD OF ADMINISTRATION OF SABIN VACCINE FOR BABIES
    不详
    JAPANESE JOURNAL OF MEDICAL SCIENCE & BIOLOGY, 1967, 20 (02): : 151 - &
  • [27] NON-NEUROVIRULENT, GENETICALLY STABLE CLONE OF POLIOVIRUS (SABIN TYPE-III VACCINE STRAIN)
    UBERTINI, TR
    CIONI, C
    PERINI, L
    GAGNONI, S
    VACCINE, 1988, 6 (06) : 481 - 482
  • [28] Development of inactivated poliovirus vaccine derived from Sabin strains
    Simizu, B
    Abe, S
    Yamamoto, H
    Tano, Y
    Ota, Y
    Miyazawa, M
    Horie, H
    Satoh, K
    Wakabayashi, K
    BIOLOGICALS, 2006, 34 (02) : 151 - 154
  • [29] Physicochemical Characterization of Sabin Inactivated Poliovirus Vaccine for Process Development
    Torisu, Tetsuo
    Shikama, Saori
    Nakamura, Kuniaki
    Enomoto, Kanta
    Maruno, Takahiro
    Mori, Asuka
    Uchiyama, Susumu
    Satou, Tatsuki
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 110 (05) : 2121 - 2129
  • [30] Sabin Vaccine Reversion in the Field: a Comprehensive Analysis of Sabin-Like Poliovirus Isolates in Nigeria
    Famulare, Michael
    Chang, Stewart
    Iber, Jane
    Zhao, Kun
    Adeniji, Johnson A.
    Bukbuk, David
    Baba, Marycelin
    Behrend, Matthew
    Burns, Cara C.
    Oberste, M. Steven
    JOURNAL OF VIROLOGY, 2016, 90 (01) : 317 - 331